Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05009589 · ClinicalTrials.gov registry record
HUDDLE: Heart Health: Understanding & Diagnosing Disease by Leveraging Echocardiograms
A clinical trial of Cardiovascular Diseases and Heart Diseases, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- 552
- Enrollment target
- 1
- Study location
NCT05009589: Completed study of Cardiovascular Diseases and Heart Diseases, sponsored by Edwards Lifesciences.
NCT05009589 is a study of Cardiovascular Diseases and Heart Diseases that has completed, run by Edwards Lifesciences. The registered enrollment target is 552 participants, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05009589, a study of Cardiovascular Diseases and Heart Diseases, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- 552 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will screen for the presence of cardiovascular disease and provide education about the signs and symptoms of cardiovascular disease and heart disease.
Primary Outcome
The number of patients with abnormal structural heart findings as identified by echocardiography
Conditions Studied
Study Locations (1)
California
- Lifewellness Institute - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 552 participants |
| Start Date | 2021-07-14 |
| Est. Completion | 2022-10-07 |
What the finished NCT05009589 record still lists
NCT05009589 is an observational study that tracks outcomes without assigning an intervention. The registered 552 participants enrollment target is mid-sized for trials with a published cap, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT05009589 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05009589 about?
NCT05009589 is a clinical study titled "HUDDLE: Heart Health: Understanding & Diagnosing Disease by Leveraging Echocardiograms". This study will screen for the presence of cardiovascular disease and provide education about the signs and symptoms of cardiovascular disease and heart disease.
What is the current status of trial NCT05009589?
This trial is currently completed. The enrollment target is 552 participants. The study started on 2021-07-14. Estimated completion is 2022-10-07.
What conditions does trial NCT05009589 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Heart Diseases.
Who is sponsoring clinical trial NCT05009589?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05009589 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05009589's enrollment target sits among peer trials
552 90th of 300 higher than 211 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06217809 · 552 participants · NA
EmpowHer is Prevention Curriculum for Youth Ages 10-15 Years.
- NCT07146022 · 552 participants · Phase 3
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
- NCT05786924 · 554 participants · Phase 1
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI